Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000033888Phase 4Not yet recruiting
Phase 4, randomised trial of metahydroxylamine in hypotension (4 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoint: blood pressure. Planned start Jun 2020; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000033888.